<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39403411</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-5588</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Chinese medical journal pulmonary and critical care medicine</Title><ISOAbbreviation>Chin Med J Pulm Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Patterns and trends in asthma incidence rates in main Asian and Western countries and their prediction to 2030.</ArticleTitle><Pagination><StartPage>188</StartPage><EndPage>196</EndPage><MedlinePgn>188-196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pccm.2024.08.004</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The urbanization and industrialization of East and Southeast Asia in decades past has significantly altered living environment and lifestyles, which may have complicated effects on the burden of asthma. We aim to examine the patterns and trends of asthma incidence rates in six major East and Southeast Asian countries as well as five major Western countries, and predict the numbers of new cases attributed to various factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data on annual asthma incident cases and corresponding population by age group were drawn from 6 major selected East and Southeast Asian countries available in the Global Burden of Disease database, including China, Japan, Korea, Singapore, Philippines, and Thailand. We also collected data of five major high-income Western countries for comparative purposes. Two separate Bayesian age-period-cohort models, representing pre-COVID (model 1) and post-COVID (model 2) scenarios, were constructed to predict the asthma incidence until 2030.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In model 1, the age-standardized incidence rate of asthma will be the highest in the US (1970.07 per 100,000, 95% confidence interval [CI] 533.05-4455.03), while the lowest incidence rate will be found in Singapore (296.72 per 100,000, 95% CI 135.16-899.55) in 2030. Between 1990 and 2030, the incidence of asthma is projected to increase in China and Thailand, with average annual percentages changes (AAPC) ranging from 0.70% to 1.80%. The remaining four Asian countries show a declining trend, with AAPC ranging from -0.51% to -2.00%. In model 2, the US is estimated to have the highest age-standardized incidence rate (902.71 per 100,000, 95% CI 375.44-2277.24), while Korea will have the lowest incidence rate (176.46 per 100,000, 95% CI 58.77-512.09) in 2030. A decrease in asthma incidence was observed in all countries with the overall AAPC ranging from -3.42% to -0.42%. Notably, a turning point was found around 2020, after which the incidence rates dropped significantly.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Pandemic-related factors may temporarily lower the incidence of asthma. The expected increasing asthma incidence in pre-COVID scenario (model 1) should still warrant attention from public health practitioners and call for efforts to reduce the burden of asthma.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Allergy, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Gan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Allergy, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ya-Dong</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Allergy, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Chin Med J Pulm Crit Care Med</MedlineTA><NlmUniqueID>9918627881206676</NlmUniqueID><ISSNLinking>2772-5588</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Bayesian age–period–cohort model</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019 (COVID-19)</Keyword><Keyword MajorTopicYN="N">East and Southeast Asia</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39403411</ArticleId><ArticleId IdType="pmc">PMC11471091</ArticleId><ArticleId IdType="doi">10.1016/j.pccm.2024.08.004</ArticleId><ArticleId IdType="pii">S2772-5588(24)00053-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56 doi: 10.1183/13993003.02094-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02094-2020</ArticleId><ArticleId IdType="pubmed">32972987</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. 2023 GINA report for asthma. Lancet Respir Med. 2023;11:589. doi: 10.1016/S2213-2600(23)00230-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00230-8</ArticleId><ArticleId IdType="pubmed">37302397</ArticleId></ArticleIdList></Reference><Reference><Citation>Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic endotypes and phenotypes of asthma. J Allergy Clin Immunol Pract. 2020;8:429–440. doi: 10.1016/j.jaip.2019.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.11.008</ArticleId><ArticleId IdType="pmc">PMC7569362</ArticleId><ArticleId IdType="pubmed">32037107</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher MI, Rutter CE, Bissell K, et al. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021;398:1569–1580. doi: 10.1016/S0140-6736(21)01450-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01450-1</ArticleId><ArticleId IdType="pmc">PMC8573635</ArticleId><ArticleId IdType="pubmed">34755626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Hao X, Chen S, Wei P. Calling for improved pulmonary and critical care medicine in China and beyond. Chin Med J Pulmonary Crit Care Med. 2023;1:1–2. doi: 10.1016/j.pccm.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pccm.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC11332819</ArticleId><ArticleId IdType="pubmed">39170875</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Garshick E, Weschler LB, et al. Home environmental and lifestyle factors associated with asthma, rhinitis and wheeze in children in Beijing. China. Environ Pollut. 2020;256 doi: 10.1016/j.envpol.2019.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envpol.2019.113426</ArticleId><ArticleId IdType="pmc">PMC7050389</ArticleId><ArticleId IdType="pubmed">31672368</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46:622–639. doi: 10.1183/13993003.00853-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00853-2015</ArticleId><ArticleId IdType="pmc">PMC4554554</ArticleId><ArticleId IdType="pubmed">26206872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagayama K, Fukutomi Y, Nakatani E, et al. Longitudinal changes in the prevalence of adult asthma: an epidemiological survey among Japanese salaried employees and their dependents using healthcare insurance claim from 1999 to 2019. Allergol Int. 2023;72:245–251. doi: 10.1016/j.alit.2022.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2022.11.002</ArticleId><ArticleId IdType="pubmed">36443222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin YH, Hwang J, Kwon R, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Allergy. 2023;78:2232–2254. doi: 10.1111/all.15807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15807</ArticleId><ArticleId IdType="pmc">PMC10529296</ArticleId><ArticleId IdType="pubmed">37431853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Li Y, Gao Y, et al. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res. 2023;24:169. doi: 10.1186/s12931-023-02475-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02475-6</ArticleId><ArticleId IdType="pmc">PMC10288698</ArticleId><ArticleId IdType="pubmed">37353829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K, Huang J, Xie S, et al. Temporal trend in burden of asthma in China, South Korea, and Japan, 1990-2019: results from the Global Burden of Disease Study 2019. J Thorac Dis. 2023;15:2559–2570. doi: 10.21037/jtd-23-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-23-22</ArticleId><ArticleId IdType="pmc">PMC10267928</ArticleId><ArticleId IdType="pubmed">37324067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosse E, Winship C. Analyzing age-period-cohort data: a review and critique. Annu Rev Sociol. 2019;45:467–492. doi: 10.1146/annurev-soc-073018-022616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-soc-073018-022616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell A. Routledge; New York, NY: 2020. Age, period and cohort effects: statistical analysis and the identification problem.</Citation></Reference><Reference><Citation>Havulinna AS. Bayesian age-period-cohort models with versatile interactions and long-term predictions: mortality and population in Finland 1878-2050. Stat Med. 2014;33:845–856. doi: 10.1002/sim.5954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5954</ArticleId><ArticleId IdType="pubmed">24105769</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TR, Wakefield J. A review and comparison of age–period–cohort models for cancer incidence. Statist Sci. 2016;31:591–610. doi: 10.1214/16-STS580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/16-STS580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Zheng Y, Wang HL, Wu J. Global patterns and trends in gastric cancer incidence rates (1988-2012) and Predictions to 2030. Gastroenterology. 2021;161:116–127.e8. doi: 10.1053/j.gastro.2021.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.03.023</ArticleId><ArticleId IdType="pubmed">33744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Møller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev. 2002;11(Suppl 1):S1–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">12442806</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SA, Quint JK, Sheikh A. Impact of COVID-19 pandemic on asthma exacerbations: retrospective cohort study of over 500,000 patients in a national English primary care database. Lancet Reg Health Eur. 2022;19 doi: 10.1016/j.lanepe.2022.100428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100428</ArticleId><ArticleId IdType="pmc">PMC9213032</ArticleId><ArticleId IdType="pubmed">35756853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouis P, Lemonaris M, Xenophontos E, Panayiotou A, Yiallouros PK. The impact of COVID-19 lockdown measures on symptoms control in children with asthma: a systematic review and meta-analysis of observational cohort studies. Pediatr Pulmonol. 2023;58:3213–3226. doi: 10.1002/ppul.26646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26646</ArticleId><ArticleId IdType="pubmed">37606188</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto N, Kadowaki T, Takanaga S, Ikeda M, Yorifuji T. Impact of COVID-19 pandemic-associated reduction in respiratory viral infections on childhood asthma onset in Japan. J Allergy Clin Immunol Pract. 2022;10:3306–3308.e2. doi: 10.1016/j.jaip.2022.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2022.09.024</ArticleId><ArticleId IdType="pmc">PMC9511876</ArticleId><ArticleId IdType="pubmed">36174920</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton DB, Neikirk AL, Yang Y, et al. Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States. Respir Res. 2023;24:72. doi: 10.1186/s12931-023-02377-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02377-7</ArticleId><ArticleId IdType="pmc">PMC9999066</ArticleId><ArticleId IdType="pubmed">36899362</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin D, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection. Lancet Respir Med. 2020;8:436–438. doi: 10.1016/S2213-2600(20)30167-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30167-3</ArticleId><ArticleId IdType="pmc">PMC7270536</ArticleId><ArticleId IdType="pubmed">32251625</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RL, Schuh H, Chandran A, et al. Incidence rates of childhood asthma with recurrent exacerbations in the US Environmental influences on Child Health Outcomes (ECHO) program. J Allergy Clin Immunol. 2023;152:84–93. doi: 10.1016/j.jaci.2023.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2023.03.016</ArticleId><ArticleId IdType="pmc">PMC10330473</ArticleId><ArticleId IdType="pubmed">36972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson CC, Chandran A, Havstad S, et al. US childhood asthma incidence rate patterns from the ECHO consortium to identify high-risk groups for primary prevention. JAMA Pediatr. 2021;175:919–927. doi: 10.1001/jamapediatrics.2021.0667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.0667</ArticleId><ArticleId IdType="pmc">PMC8129904</ArticleId><ArticleId IdType="pubmed">33999100</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson CC, Havstad SL, Ownby DR, et al. Pediatric asthma incidence rates in the United States from 1980 to 2017. J Allergy Clin Immunol. 2021;148:1270–1280. doi: 10.1016/j.jaci.2021.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.04.027</ArticleId><ArticleId IdType="pmc">PMC8631308</ArticleId><ArticleId IdType="pubmed">33964299</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng SZ, Jalaludin BB, Antó JM, Hess JJ, Huang CR. Climate change, air pollution, and allergic respiratory diseases: a call to action for health professionals. Chin Med J (Engl) 2020;133:1552–1560. doi: 10.1097/CM9.0000000000000861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000861</ArticleId><ArticleId IdType="pmc">PMC7386356</ArticleId><ArticleId IdType="pubmed">32590458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wu Z, Gou K, Wang R, Wang J. The Impact of Air Pollution on Outpatient Visits of Children with Asthma in Xi'an, China. Wilderness Environ Med. 2021;32:47–54. doi: 10.1016/j.wem.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wem.2020.11.006</ArticleId><ArticleId IdType="pubmed">33518497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Kim H, Lee JT. Effect of air pollutant emission reduction policies on hospital visits for asthma in Seoul, Korea; Quasi-experimental study. Environ Int. 2019;132 doi: 10.1016/j.envint.2019.104954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2019.104954</ArticleId><ArticleId IdType="pubmed">31400599</ArticleId></ArticleIdList></Reference><Reference><Citation>Legaspi K, Dychiao R, Dee EC, Kho-Dychiao RM, Ho F. Pediatric asthma in the Philippines: risk factors, barriers, and steps forward across the child's life stages. Lancet Reg Health West Pac. 2023;35 doi: 10.1016/j.lanwpc.2023.100806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100806</ArticleId><ArticleId IdType="pmc">PMC10326682</ArticleId><ArticleId IdType="pubmed">37424689</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunrat N, Pumijumnong N, Sereenonchai S. Air-pollutant emissions from agricultural burning in Mae Chaem Basin, Chiang Mai province, Thailand. Atmosphere. 2018;9:145. doi: 10.3390/atmos9040145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/atmos9040145</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang J, Song G, et al. Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in China. Clin Transl Allergy. 2022;12:e12116. doi: 10.1002/clt2.12116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clt2.12116</ArticleId><ArticleId IdType="pmc">PMC8809046</ArticleId><ArticleId IdType="pubmed">35136540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Ding M, Zhang J, et al. Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma. Chin Med J (Engl) 2022;135:519–531. doi: 10.1097/CM9.0000000000001983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000001983</ArticleId><ArticleId IdType="pmc">PMC8920422</ArticleId><ArticleId IdType="pubmed">35170505</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Zhang K, Zhang X, et al. Association between living habits, indoor humidity, ventilation and asthma among residents in the tropical regions of China. Front Public Health. 2023;11 doi: 10.3389/fpubh.2023.1294115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1294115</ArticleId><ArticleId IdType="pmc">PMC10684788</ArticleId><ArticleId IdType="pubmed">38035300</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WJ, Wong G. Changing trends and challenges in the management of asthma in Asia. J Allergy Clin Immunol. 2017;140:1272–1274. doi: 10.1016/j.jaci.2017.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.09.008</ArticleId><ArticleId IdType="pubmed">28964883</ArticleId></ArticleIdList></Reference><Reference><Citation>To T, Stanojevic S, Feldman R, et al. Is asthma a vanishing disease? A study to forecast the burden of asthma in 2022. BMC Public Health. 2013;13:254. doi: 10.1186/1471-2458-13-254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-254</ArticleId><ArticleId IdType="pmc">PMC3626860</ArticleId><ArticleId IdType="pubmed">23517452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurbet MF, Rojano B, Whittaker Brown SA, et al. Obesity Trends among Asthma Patients in the United States: A Population-based Study. Ann Glob Health. 2019;85:10. doi: 10.5334/aogh.2420.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/aogh.2420</ArticleId><ArticleId IdType="pmc">PMC7052313</ArticleId><ArticleId IdType="pubmed">30741512</ArticleId></ArticleIdList></Reference><Reference><Citation>Beggs PJ, Clot B, Sofiev M, Johnston FH. Climate change, airborne allergens, and three translational mitigation approaches. EBioMedicine. 2023;93 doi: 10.1016/j.ebiom.2023.104478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104478</ArticleId><ArticleId IdType="pmc">PMC10363419</ArticleId><ArticleId IdType="pubmed">36805358</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutner C, Werchan B, Forkel S, et al. Sensitization rates to common inhaled allergens in Germany - increase and change patterns over the last 20 years. J Dtsch Dermatol Ges. 2021;19:37–44. doi: 10.1111/ddg.14312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ddg.14312</ArticleId><ArticleId IdType="pubmed">33103355</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amato G, Chong-Neto HJ, Monge Ortega OP, et al. The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy. 2020;75:2219–2228. doi: 10.1111/all.14476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14476</ArticleId><ArticleId IdType="pubmed">32589303</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan BM, Abreo A, Ding T, et al. Dose, timing, and type of infant antibiotic use and the risk of childhood asthma. Clin Infect Dis. 2020;70:1658–1665. doi: 10.1093/cid/ciz448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz448</ArticleId><ArticleId IdType="pmc">PMC7145998</ArticleId><ArticleId IdType="pubmed">31149702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook Q, Argenio K, Lovinsky-Desir S. The impact of environmental injustice and social determinants of health on the role of air pollution in asthma and allergic disease in the United States. J Allergy Clin Immunol. 2021;148:1089–1101.e5. doi: 10.1016/j.jaci.2021.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.09.018</ArticleId><ArticleId IdType="pubmed">34743831</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverwood RJ, Rutter CE, Mitchell EA, et al. Are environmental risk factors for current wheeze in the international study of asthma and allergies in childhood (ISAAC) phase three due to reverse causation. Clin Exp Allergy. 2019;49:430–441. doi: 10.1111/cea.13325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13325</ArticleId><ArticleId IdType="pmc">PMC6487816</ArticleId><ArticleId IdType="pubmed">30508327</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mutius E. The microbial environment and its influence on asthma prevention in early life. J Allergy Clin Immunol. 2016;137:680–689. doi: 10.1016/j.jaci.2015.12.1301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.12.1301</ArticleId><ArticleId IdType="pubmed">26806048</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407–418. doi: 10.1016/S0140-6736(19)31147-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31147-X</ArticleId><ArticleId IdType="pubmed">31230828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Wang W, Chen P, et al. Prevalence and risk factors of asthma in mainland China: The CARE study. Respir Med. 2018;137:48–54. doi: 10.1016/j.rmed.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.02.010</ArticleId><ArticleId IdType="pubmed">29605212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J, Ho A, Jou E, Liu N, Zheng H, Aik J. Association between the extension of smoke-free legislation and incident acute myocardial infarctions in Singapore from 2010 to 2019: an interrupted time-series analysis. BMJ Glob Health. 2023;8 doi: 10.1136/bmjgh-2023-012339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012339</ArticleId><ArticleId IdType="pmc">PMC10565237</ArticleId><ArticleId IdType="pubmed">37816537</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttriss JL, Lanham-New SA, Steenson S, et al. Implementation strategies for improving vitamin D status and increasing vitamin D intake in the UK: current controversies and future perspectives: proceedings of the 2nd Rank Prize Funds Forum on vitamin D. Br J Nutr. 2022;127:1567–1587. doi: 10.1017/S0007114521002555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114521002555</ArticleId><ArticleId IdType="pmc">PMC8376911</ArticleId><ArticleId IdType="pubmed">34284830</ArticleId></ArticleIdList></Reference><Reference><Citation>Box GEP. Science and statistics. J Am Statis Assoc. 1976;71:791–799. doi: 10.2307/2286841.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2286841</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>